Medistim ASA/Nkr MEDI
08:00
09:50
11:40
13:30
15:20
1D1W1MYTD1Y5YMAX
About Medistim ASA
Medistim ASA is a Norwegian company specializing in the development and commercialization of medical devices used in cardiac, vascular, and transplant surgery. Its core business focuses on intraoperative blood flow measurement technology, notably through its proprietary products like the VeriQ and MiraQ systems. These systems are crucial for ensuring optimal blood flow during surgeries, thus helping to improve clinical outcomes. Founded in 1984, Medistim is headquartered in Oslo, Norway, and operates with a global network, distributing its products worldwide. The company's strategic strengths lie in its specialized focus on niche surgical applications and its continued innovation in medical technology.
Ticker
Nkr MEDI
Sector
Primary listing
XOSL
Employees
154
Headquarters
Oslo, Norway
Website
Medistim ASA Metrics
BasicAdvanced
kr 3.9B
24.45
kr 8.71
1.06
kr 6.00
2.82%
Price and volume
Market cap
kr 3.9B
Beta
1.06
52-week high
kr 292.00
52-week low
kr 153.00
Average daily volume
47K
Dividend rate
kr 6.00
Financial strength
Current ratio
3.336
Quick ratio
2.211
Long term debt to equity
8.006
Total debt to equity
8.006
Dividend payout ratio (TTM)
68.76%
Profitability
EBITDA (TTM)
210.075
Gross margin (TTM)
81.68%
Net profit margin (TTM)
22.75%
Operating margin (TTM)
28.04%
Effective tax rate (TTM)
23.03%
Revenue per employee (TTM)
kr 4,540,000
Management effectiveness
Return on assets (TTM)
19.85%
Return on equity (TTM)
35.18%
Valuation
Price to earnings (TTM)
24.455
Price to revenue (TTM)
5.563
Price to book
8.39
Price to tangible book (TTM)
10.54
Price to free cash flow (TTM)
20.321
Free cash flow yield (TTM)
4.92%
Free cash flow per share (TTM)
10.482
Dividend yield (TTM)
2.82%
Forward dividend yield
2.82%
Growth
Revenue change (TTM)
25.82%
Earnings per share change (TTM)
53.63%
3-year revenue growth (CAGR)
12.90%
10-year revenue growth (CAGR)
10.84%
3-year earnings per share growth (CAGR)
11.76%
10-year earnings per share growth (CAGR)
14.60%
3-year dividend per share growth (CAGR)
21.14%
10-year dividend per share growth (CAGR)
17.10%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Medistim ASA stock?
Medistim ASA (MEDI) has a market cap of Nkr3.9B as of March 23, 2026.
What is the P/E ratio for Medistim ASA stock?
The price to earnings (P/E) ratio for Medistim ASA (MEDI) stock is 24.45 as of March 23, 2026.
Does Medistim ASA stock pay dividends?
Yes, the Medistim ASA (MEDI) stock pays dividends to shareholders. As of March 23, 2026, the dividend rate is Nkr6 and the yield is 2.82%. Medistim ASA has a payout ratio of 68.76% on a trailing twelve-month basis.
When is the next Medistim ASA dividend payment date?
The next Medistim ASA (MEDI) dividend payment date is unconfirmed.
What is the beta indicator for Medistim ASA?
Medistim ASA (MEDI) has a beta rating of 1.06. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.